# A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

> **NCT06116565** · PHASE2 · UNKNOWN · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 300 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT06116565
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-30
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06116565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06116565, "A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06116565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*